Index AR1 - Anticancer Research

More documents

Recommendations

Info

Subject Index (Figures refer to page numbers) 518A2Ι, radioiodinated methylene blue, melanoma imaging, SK-MEL 28, 3691 A20 leukemia/lymphoma, immature dendritic cells, cytotoxic T lymphocytes, co-culture, syngeneic, GM-CSF, 2831 A431, MMP-2, MMP-9, FAK, Boyden chamber assay, 2109 ABC transporters, non-small cell lung cancer, COX-2, chemotherapy, 2967 ABCB1 gene, colon cancer, P-glycoprotein, polymorphisms, immunohistochemistry, 3921 Abnormality, medulloblastoma, neuroimaging, 3991 Absolute hardness, 3-formylchromone derivatives, QSAR, cytotoxicity, semiempirical molecular-orbital method, 277 Absolute hardness, 5-trifluoromethyloxazole derivatives, QSAR, cytotoxicity, semiempirical molecular-orbital method, 997 Acceleration, capecitabine, radiotherapy, surgery, hypofractionation, amifostine, rectal cancer, 3035 Acceleration, non-small cell lung cancer, vinorelbine, liposomal doxorubicin, hypofractionation, amifostine, radiotherapy, 1349 Accessibility, ethnic minority, Māori, Pacific Island, diagnosis, treatment, 3891 Accuracy of diagnosis, prostate cancer, proton magnetic resonance spectroscopy, prostate biopsy, 1899 Acne, steroid sulphatase, oestrogen, androgen, breast cancer, skin, hirsutism, sulphatase inhibitor, 1517 AcSDKP, POP, marker, angiogenesis, thyroid tumor, cancer, 2813 ACT, prostate cancer, inflammation, promoter polymorphism, PSA levels, 395 Activation, lymphocytes, 5-fluorouracil, 3785 Acute leukemia, Wnt, β-catenin, self-renewal, Notch, 2701 Acute myeloid leukemia, children, drug resistance, drug sensitivity, prognostic factors, 1927 Acute myeloid leukemia, PDGFR, single-strand conformation polymorphism, core-binding factor, 2745 Adenocarcinoma, Gaucher’s disease, hematological toxicity, non-small cell lung cancer, cytopenia, chemotherapy, 3937 Adenocarcinoma, metastatic brain tumor, MRI, mucin, 407 Adenoma, polyp, primary culture, carcinogenesis, cell culture, 843 Adenomas, paneth cells, stem cells, turnover, 1571 Adenomatous polyposis coli, inherited cancer syndrome, HNPCC, BRCA1, BRCA2, MEN 2, review, 1341 Adenovirus vector, gene therapy, CD40 ligand, rat, metastatic liver cancer, 2785 Adenovirus vector, gene therapy, hepatocellular carcinoma, arterial injection, iodized oil, rat, 51 ANTICANCER RESEARCH 28: Index (2008) Adenovirus, gene therapy, thymidine kinase, Coxackieadenovirus receptor, ovarian cancer, 2569 Adenovirus, snail, E-cadherin, metastasis, 621 Adhesion, hypoxia, spheroids, integrin, fibronectin, 1013 Adhesion, megakaryocytic, erythroid, lineage shift, fibronectin, integrin, 261 Adipose tissue, lipoprotein lipase, sarcoma, triacylglycerol, 2081 Adjuvant chemotherapy, advanced gastric cancer, palliative gastrectomy, 1309 Adjuvant chemotherapy, elderly, colon cancer, 2513 Adjuvant chemotherapy, endometrial cancer, grade 3 tumor, 1785 Adjuvant chemotherapy, rectal cancer, 1805 Adjuvant chemotherapy, UFT, LV, micrometastasis, 2045 Adjuvant tamoxifen, endometrial carcinoma, breast cancer, ultrasound, 1259 Adjuvant therapy, DNAses, prognosis, vitamin C, vitamin K 3 , review, 2727 Adjuvant therapy, lung cancer, immunotherapy, N2 disease, surgery, dendritic cell, regional lymph node, 1229 Adjuvant therapy, VEGF-1 expression, colorectal cancer, prognosis, 3865 Adjuvant, vaccine, cancer, resection, Lobund-Wistar rat, 2529 ADP ribose, PARP, temozolomide, preclinical efficacy, biomarker, 2625 Adrenocortical, incidentaloma, proliferation markers, metallothioneins, minichromosome maintenance protein, Ki-67, 2959 Advanced colorectal cancer, bevacizumab, irinotecan, capecitabine, 3087 Advanced colorectal cancer, weekly irinotecan, protracted venous infusion fluorouracil, 2327 Advanced gastric cancer, adjuvant chemotherapy, palliative gastrectomy, 1309 Advanced gastric cancer, chemotherapy, phase I study, toxicity, 2473 Advanced gastric cancer, gastrectomy, non-curative factor, prognostic factor, 2379 Advanced non-small cell lung cancer, erlotinib, monotherapy, 2409 Advanced pancreatic cancer, S-1, cisplatin, phase Ⅱ study, 2373 Advanced, myelotoxicity, chemotherapy, prognosis, breast cancer, 2913 African Americans, Cox-2 polymorphisms, colorectal adenoma, 3119 Age, radiotherapy, brain metastasis, prognostic factors, malignant melanoma, 1325 Age-specific expression, cervical cancer, markers, p53, p27, COX-2, Ki-67, EGFR, E-cadherin, c-myc, VEGF, CD44, CD4, 1793 4221
Aggrecan, versican, decorin, Western blotting, immunohistochemistry, RT-PCR, proteoglycan, 245 Akt, prohibitin, transformation, 957 AKT, PTEN, mTOR, p53, genome stability, cell cycle, review, 3613 Albendazole, β-cyclodextrin, ovarian cancer, efficacy, toxicity, 2775 Alcohol, cancer, risk, diet, iron, legumes, meat, smoking, supplements, urban, ultraviolet-B, vitamin D, whole grains, zinc, 1955 Alkaline sphingomyelinase, sphingomyelin, colon cancer, mouse, 3631 Allele-specific PCR, epidermal growth factor receptor, gefitinib, mutation screening, non-small cell lung cancer, 2265 Allelic discrimination, bladder cancer, single nucleotide polymorphism, ERCC2, XPC, XRCC1, XRCC3, 1853 Alpha-folate receptor, ovarian carcinoma, folate receptor overexpression, targeted therapy, 3567 Amelanotic melanoma, ovarian metastasis, 563 Ameloblastic carcinoma, ameloblastoma, oral cavity, 3847 Ameloblastoma, ameloblastic carcinoma, oral cavity, 3847 Amifostine, capecitabine, radiotherapy, surgery, acceleration, hypofractionation, rectal cancer, 3035 Amifostine, non-small cell lung cancer, vinorelbine, liposomal doxorubicin, hypofractionation, acceleration, radiotherapy, 1349 Amino acid transport system L, LAT1, salivary gland carcinoma cells, essential amino acids, antitumor therapy, 2649 Amino acids, human tumors, nude mice, methionine metabolism, transulfuration, 2541 Amplification, EGFR, EGFRvIII, glioblastoma, glioma, oligodendroglioma, 913 Ampullary cancer, pancreatic cancer, MMPs, TIMPs, MVD, 1875 Amrubicin, NSCLC, chemotherapy failure, third-line treatment, 3855 Anal canal carcinoma, radiotherapy, chemotherapy, 1335 Anal canal, squamous carcinoma, intratumoral lymphocytes, 2469 Anandamide, anticancer immunity, cannabinoids, lymphocytes, regulatory T-cell, 3743 Anaplastic astrocytoma, glioblastoma multiforme, high grade glioma, histone deacetylase inhibitor, pediatric, valproic acid, 2437 Anaplastic large cell lymphoma, small animal PET, FDG, xenograft, NOD/SCID, 981 Anastrozole, premenopausal, mammary carcinogenesis, rat, chemoprevention, aromatase inhibitors, 2819 Androgen receptor, cannabinoids, breast cancer, estrogen receptor, 85 Androgen receptor, prostate cancer, SRC1, TIF2, Her2/neu, prognosis, radical prostatectomy, 425 4222 ANTICANCER RESEARCH 28: Index (2008) Androgen, steroid sulphatase, oestrogen, breast cancer, skin, acne, hirsutism, sulphatase inhibitor, 1517 Anemia, cancer, erythrocyte transfusion, cost-effectiveness, 459 Anemia, darbepoetin alfa, chemotherapy, supportive care, 1767 Angiogenesis, AcSDKP, POP, marker, thyroid tumor, cancer, 2813 Angiogenesis, angiotensinogen, oral cancer, polymorphism, 1675 Angiogenesis, anti-VEGFR, anti-TYRP-1/gp75, melanoma, antibody therapy, 2679 Angiogenesis, autocrine signalling, breast cancer, Flt-1, VEGF, 1719 Angiogenesis, bisphosphonates, RENCA, vessel density, VEGF, 933 Angiogenesis, hop beta-acids, angioprevention, cell proliferation, chemotaxis, VEGF, matrigel plug, 289 Angiogenesis, inflammation, MIF, IL-10, tamoxifen, aspirin, 2093 Angiogenesis, interleukin-10, oral cancer, inflammation, thrombophilia, 309 Angiogenesis, monocytes, tumour growth, cytokines, 187 Angiogenesis, oral squamous cell carcinoma, HIF-1α, VEGF-C, lymphangiogenesis, 1659 Angiogenesis, pancreatic ductal adenocarcinoma, INK4a, K-RAS, SMAD4, TP53, NF-ÎB, PI3K, SKP2, RB, p27 Kip1 , cell cycle, metastasis, proliferation, apoptosis, epigenetic gene regulation, miRNA, epithelialmesenchymal transition, chemotaxis, sonic hedgehog, review, 1541 Angiogenesis, stromal-derived factor-1, oral cancer, thrombophilia, polymorphism, 271 Angiogenesis, vinorelbine, malignant pleural effusion, lung cancer, vascular endothelial growth factor (VEGF), 1633 Angiogenesis, zoledronic acid, TNP-470, neuroblastoma, SH-SY5Y, 1551 Angioprevention, hop beta-acids, angiogenesis, cell proliferation, chemotaxis, VEGF, matrigel plug, 289 Angiosarcoma, polychemotherapy, first-line, 3041 Angiotensinogen, oral cancer, polymorphism, angiogenesis, 1675 Animal model, breast cancer, green tea catechins, fatty acid synthase, weight loss, anti-cancer drug, 3671 Animal model, radiofrequency, human breast cancer, metastasis, rats, 879 Annexin, prostate, cancer, cytokine, gp96, review, 2843 Annexin, thymax, MCF-7, apoptosis, caspases, 1603 Anthocyanins, colon cancer, differentiation, peach, plum, phenolics, 2067 Antiangiogenic therapy, vascular disrupting agents, combination therapy, renal cell carcinoma, 2027 Antibodies, colorectal cancer, metastases, chemotherapy, treatment, 4111
Page 1 and 2: ANTICANCER RESEARCH International J
Page 3 and 4: Editorial Board ANTICANCER RESEARCH
Page 5 and 6: ANTICANCER RESEARCH 28: Index (2008
Page 7 and 8: Department of Health, Executive Yua
Page 9 and 10: National R&D Program for Cancer Con
Page 11 and 12: Number 1A Experimental Studies ANTI
Page 15 and 16: * ANTICANCER RESEARCH 28: Index (20
Page 17 and 18: Amelanotic Metastasis of Melanoma M
Page 23 and 24: * ANTICANCER RESEARCH 28: Index (20
Page 25 and 26: Detection of Oncogenic DNA Viruses
Page 27 and 28: Gross Thymic Extract, Thymax, Induc
Page 31 and 32: * Number 4A Special Issue on Prosta
Page 37 and 38: Adjuvant Treatment for Elderly Pati
Page 45 and 46: * * ANTICANCER RESEARCH 28: Index (
Page 47 and 48: Number 6B Clinical Studies ANTICANC
Page 49: Abstracts of the 14th International
Page 53 and 54: Apoptosis, inotodiol, lanostane tri
Page 55 and 56: Bone metastases, bisphosphonates, z
Page 57 and 58: Capecitabine, colorectal cancer, ir
Page 59 and 60: Chemoresistance, cancer of unknown
Page 61 and 62: Colorectal adenoma, Cox-2 polymorph
Page 63 and 64: Cytotoxicity, ferrocene, β-diketon
Page 65 and 66: Electrochemiluminescence immunoassa
Page 67 and 68: Ferrocene, β-diketone, cytotoxicit
Page 69 and 70: Genistein, soy extract, MDA-MB-231
Page 71 and 72: Histone deacetylase inhibitor, vita
Page 73 and 74: Infusion, 5-fluorouracil, arterial,
Page 75 and 76: Liver metastasis, pioglitazone, col
Page 77 and 78: Melphalan, hyperthermia, apoptosis,
Page 79 and 80: Mucin, adenocarcinoma, metastatic b
Page 81 and 82: Oesophageal cancer, carboplatin, el
Page 83 and 84: P53, syndecan-1, tenascin-C, TATI,
Page 85 and 86: Plumbagin, apoptosis, pro-apoptotic
Page 87 and 88: ProGRP, small cell lung cancer, NSE
Page 89 and 90: RA-resistance, leukemia cells, reti
Page 91 and 92: S-1, cisplatin, advanced pancreatic
Page 93 and 94: Sonic hedgehog, breast cancer, estr
Page 95 and 96: Thrombosis, gynecological cancer, c
Page 97 and 98: Type of cell death, β-cyclodextrin
Page 99 and 100: Authors Index (Figures refer to pag
Page 101 and 102:
Cho S-H, 2649 Choi MS, 3777 Chorti
Page 103 and 104:
Giuliani L, 1405 Goda T, 2343 Goess
Page 105 and 106:
Katano M, 731, 2401 Katayama K, 847
Page 107 and 108:
Mahajan A, 741 Maiti A, 3705 Majka
Page 109 and 110:
Onogawa T, 2669 Onouchi S, 145 Onoz
Page 111 and 112:
Scotti M, 1951 Sculli CM, 3055 Seco
Page 113 and 114:
Usami M, 3913 Ushijima R, 601 Usui
Page 115 and 116:
Errata ANTICANCER RESEARCH 28: Inde
Page 117 and 118:
Medicherla et al: TGF-‚ Inhibitor
Page 119 and 120:
Volume 28 (2008), No 2A, page 1072:
Page 121:
Publication Data: ANTICANCER RESEAR
show all

Index AR1 - Anticancer Research

Create successful ePaper yourself

Delete template?

Save as template?